Brief: Oncology Institute- On May 11, 2022, Board Of Co Approved Share Repurchase Program With Authorization To Purchase Up To $20 Million Of Co’S Common Stock
May 12 (Reuters) - Oncology Institute Inc TOI.O :
* ONCOLOGY INSTITUTE- ON MAY 11, 2022, BOARD OF CO APPROVED
SHARE
REPURCHASE PROGRAM WITH AUTHORIZATION TO PURCHASE UP TO $20
MILLION OF CO’S COMMON STOCK
Source text for Eikon: [https://bit.ly/39P1evz]
Further company coverage: TOI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oncology Institute
See all newsOncology Institute Q1 revenue rises on specialty pharmacy growth, reaffirms 2026 revenue guidance
Brief: Oncology Institute Q1 Gross Profit USD 23.3 Million
Oncology Institute beats Q4 revenue estimates, net loss narrows
Brief: The Oncology Institute Reaffirms 2025 Guidance And Provides Preliminary 2026 Outlook
Brief: The Oncology Institute Announces Leadership Promotions